Ascentage Pharma Group International (AAPG) Common Equity (2022 - 2024)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Ascentage Pharma Group International (AAPG) has 2 years of Common Equity data on record, last reported at $36.8 million in Q4 2024.

• For Q4 2024, Common Equity rose 338.32% year-over-year to $36.8 million; the TTM value through Dec 2024 reached $36.8 million, up 338.32%, while the annual FY2024 figure was $36.8 million, 330.08% up from the prior year.
• Common Equity reached $36.8 million in Q4 2024 per AAPG's latest filing, up from $8.4 million in the prior quarter.
• Across five years, Common Equity topped out at $36.8 million in Q4 2024 and bottomed at $8.4 million in Q4 2023.

Peer Comparison